Cargando…

Narrative Review: Low-Dose Ketamine for Pain Management

Pain is the leading cause of medical consultations and occurs in 50–70% of emergency department visits. To date, several drugs have been used to manage pain. The clinical use of ketamine began in the 1960s and it immediately emerged as a manageable and safe drug for sedation and anesthesia. The anal...

Descripción completa

Detalles Bibliográficos
Autores principales: Riccardi, Alessandro, Guarino, Mario, Serra, Sossio, Spampinato, Michele Domenico, Vanni, Simone, Shiffer, Dana, Voza, Antonio, Fabbri, Andrea, De Iaco, Fabio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179418/
https://www.ncbi.nlm.nih.gov/pubmed/37176696
http://dx.doi.org/10.3390/jcm12093256
_version_ 1785041093296914432
author Riccardi, Alessandro
Guarino, Mario
Serra, Sossio
Spampinato, Michele Domenico
Vanni, Simone
Shiffer, Dana
Voza, Antonio
Fabbri, Andrea
De Iaco, Fabio
author_facet Riccardi, Alessandro
Guarino, Mario
Serra, Sossio
Spampinato, Michele Domenico
Vanni, Simone
Shiffer, Dana
Voza, Antonio
Fabbri, Andrea
De Iaco, Fabio
author_sort Riccardi, Alessandro
collection PubMed
description Pain is the leading cause of medical consultations and occurs in 50–70% of emergency department visits. To date, several drugs have been used to manage pain. The clinical use of ketamine began in the 1960s and it immediately emerged as a manageable and safe drug for sedation and anesthesia. The analgesic properties of this drug were first reported shortly after its use; however, its psychomimetic effects have limited its use in emergency departments. Owing to the misuse and abuse of opioids in some countries worldwide, ketamine has become a versatile tool for sedation and analgesia. In this narrative review, ketamine’s role as an analgesic is discussed, with both known and new applications in various contexts (acute, chronic, and neuropathic pain), along with its strengths and weaknesses, especially in terms of psychomimetic, cardiovascular, and hepatic effects. Moreover, new scientific evidence has been reviewed on the use of additional drugs with ketamine, such as magnesium infusion for improving analgesia and clonidine for treating psychomimetic symptoms. Finally, this narrative review was refined by the experience of the Pain Group of the Italian Society of Emergency Medicine (SIMEU) in treating acute and chronic pain with acute manifestations in Italian Emergency Departments.
format Online
Article
Text
id pubmed-10179418
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-101794182023-05-13 Narrative Review: Low-Dose Ketamine for Pain Management Riccardi, Alessandro Guarino, Mario Serra, Sossio Spampinato, Michele Domenico Vanni, Simone Shiffer, Dana Voza, Antonio Fabbri, Andrea De Iaco, Fabio J Clin Med Review Pain is the leading cause of medical consultations and occurs in 50–70% of emergency department visits. To date, several drugs have been used to manage pain. The clinical use of ketamine began in the 1960s and it immediately emerged as a manageable and safe drug for sedation and anesthesia. The analgesic properties of this drug were first reported shortly after its use; however, its psychomimetic effects have limited its use in emergency departments. Owing to the misuse and abuse of opioids in some countries worldwide, ketamine has become a versatile tool for sedation and analgesia. In this narrative review, ketamine’s role as an analgesic is discussed, with both known and new applications in various contexts (acute, chronic, and neuropathic pain), along with its strengths and weaknesses, especially in terms of psychomimetic, cardiovascular, and hepatic effects. Moreover, new scientific evidence has been reviewed on the use of additional drugs with ketamine, such as magnesium infusion for improving analgesia and clonidine for treating psychomimetic symptoms. Finally, this narrative review was refined by the experience of the Pain Group of the Italian Society of Emergency Medicine (SIMEU) in treating acute and chronic pain with acute manifestations in Italian Emergency Departments. MDPI 2023-05-02 /pmc/articles/PMC10179418/ /pubmed/37176696 http://dx.doi.org/10.3390/jcm12093256 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Riccardi, Alessandro
Guarino, Mario
Serra, Sossio
Spampinato, Michele Domenico
Vanni, Simone
Shiffer, Dana
Voza, Antonio
Fabbri, Andrea
De Iaco, Fabio
Narrative Review: Low-Dose Ketamine for Pain Management
title Narrative Review: Low-Dose Ketamine for Pain Management
title_full Narrative Review: Low-Dose Ketamine for Pain Management
title_fullStr Narrative Review: Low-Dose Ketamine for Pain Management
title_full_unstemmed Narrative Review: Low-Dose Ketamine for Pain Management
title_short Narrative Review: Low-Dose Ketamine for Pain Management
title_sort narrative review: low-dose ketamine for pain management
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179418/
https://www.ncbi.nlm.nih.gov/pubmed/37176696
http://dx.doi.org/10.3390/jcm12093256
work_keys_str_mv AT riccardialessandro narrativereviewlowdoseketamineforpainmanagement
AT guarinomario narrativereviewlowdoseketamineforpainmanagement
AT serrasossio narrativereviewlowdoseketamineforpainmanagement
AT spampinatomicheledomenico narrativereviewlowdoseketamineforpainmanagement
AT vannisimone narrativereviewlowdoseketamineforpainmanagement
AT shifferdana narrativereviewlowdoseketamineforpainmanagement
AT vozaantonio narrativereviewlowdoseketamineforpainmanagement
AT fabbriandrea narrativereviewlowdoseketamineforpainmanagement
AT deiacofabio narrativereviewlowdoseketamineforpainmanagement